Literature DB >> 2918655

Hyperprolactinemia and nonpuerperal mastitis (duct ectasia).

F Peters1, W Schuth.   

Abstract

In 108 patients with nonpuerperal mastitis (inflammatory symptoms of duct ectasia), serum prolactin levels were determined before, during, and after treatment. Twenty-nine patients (26.8%) exhibited transiently elevated prolactin levels during the period of inflammation (mean +/- SD level, 42 +/- 22 micrograms/L) that returned to normal within 4 weeks. Twenty-two patients (20.4%) presented with more severe hyperprolactinemia (78 +/- 56 micrograms/L), and 15 were found to have pituitary microadenomas. In 11 cases, mastitis was the first symptom of hyperprolactinemia. A second group of 83 patients with known hyperprolactinemia and 83 normoprolactinemic controls were interviewed with regard to recent symptoms or past treatment of nonpuerperal mastitis. Sixteen hyperprolactinemic women (19.3%) and none of the controls reported that they had experienced mastitis. We conclude that duct ectasia is due in part to increased prolactin secretion. Thus, nonpuerperal mastitis may be a symptom of hyperprolactinemia. On the other hand, nonpuerperal mastitis may induce transient hyperprolactinemia (neurogenic hyperprolactinemia) of about 3 weeks' duration that is less pronounced than central hyperprolactinemia.

Entities:  

Mesh:

Year:  1989        PMID: 2918655

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

1.  Treatment of mammary duct fistula by fistulectomy and saucerization.

Authors:  N Beechey-Newman; A Kothari; D Kulkarni; H Hamed; I S Fentiman
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

2.  Duct ectasia in an accessory breast successfully treated with a flap technique: a case report.

Authors:  Xiaohui Zhang; Stephen R Grobmyer; Yujing Wang; Qiang Sun; Hanyuan Huang
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.

Authors:  S Gill; D Peston; B K Vonderhaar; S Shousha
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  Bilateral mammary duct ectasia induced by sulpiride-associated hyperprolactinemia: A case report.

Authors:  Yizi Cong; Haidong Zou; Guangdong Qiao; Jun Lin; Xingmiao Wang; Xiaohui Li; Yalun Li; Shiguang Zhu
Journal:  Oncol Lett       Date:  2015-03-12       Impact factor: 2.967

Review 5.  Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?

Authors:  Mengying Xing; Shichang Zhang; Xiaoming Zha; Jiexin Zhang
Journal:  Breast Care (Basel)       Date:  2021-10-06       Impact factor: 2.268

6.  Risk factors for histologically confirmed benign breast tumors.

Authors:  M Rautalahti; D Albanes; J Haukka; J Virtamo
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

Review 7.  Management of nipple discharge.

Authors:  H P Leis
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

8.  Diffusion-weighted imaging in relation to morphology on dynamic contrast enhancement MRI: the diagnostic value of characterizing non-puerperal mastitis.

Authors:  Lina Zhang; Jiani Hu; Nicholas Guys; Jinli Meng; Jianguo Chu; Weisheng Zhang; Ailian Liu; Shaowu Wang; Qingwei Song
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.